StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 6/30
$2.06+0.10 (+5.10%)

Close on Nov 18, 2026Market cap $19.86MP/E –Yield –

Edesa Biotech operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Edesa Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$8.91M. For fiscal 2025 it was -$7.32M. The highest annual figure on record is -$2.80M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$7.32M–
FY2024Sep 30, 2024-$4.89M–
FY2023Sep 30, 2023-$6.64M–
FY2022Sep 30, 2022-$12.28M–
FY2021Sep 30, 2021-$13.66M–
FY2020Sep 30, 2020-$4.99M–
FY2018Sep 30, 2018-$4.62M–
FY2017Sep 30, 2017-$4.70M–
FY2016Sep 30, 2016-$4.51M–
FY2014Aug 31, 2014-$4.27M–
FY2013Aug 31, 2013-$2.80M–
FY2012Aug 31, 2012-$3.95M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$3.08M–
Q2 FY2026CQ1 2026Mar 31, 2026-$2.02M–
Q1 FY2026CQ4 2025Dec 31, 2025-$2.09M–
Q4 FY2025CQ3 2025Sep 30, 2025-$1.72M–
Q3 FY2025CQ2 2025Jun 30, 2025-$1.70M–
Q2 FY2025CQ1 2025Mar 31, 2025-$2.38M–
Q1 FY2025CQ4 2024Dec 31, 2024-$1.52M–
Q4 FY2024CQ3 2024Sep 30, 2024-$967.04K–
Q3 FY2024CQ2 2024Jun 30, 2024-$856.48K–
Q2 FY2024CQ1 2024Mar 31, 2024-$1.66M–
Q1 FY2024CQ4 2023Dec 31, 2023-$1.41M–
Q4 FY2023CQ3 2023Sep 30, 2023-$1.47M–
Q3 FY2023CQ2 2023Jun 30, 2023-$1.81M–
Q2 FY2023CQ1 2023Mar 31, 2023-$1.57M–
Q1 FY2023CQ4 2022Dec 31, 2022-$1.79M–
Q4 FY2022CQ3 2022Sep 30, 2022-$5.63M–
Q3 FY2022CQ2 2022Jun 30, 2022-$3.03M–
Q2 FY2022CQ1 2022Mar 31, 2022-$416.65K–
Q1 FY2022CQ4 2021Dec 31, 2021-$3.21M–
Q4 FY2021CQ3 2021Sep 30, 2021-$355.32K–
Q3 FY2021CQ2 2021Jun 30, 2021-$3.12M–
Q2 FY2021CQ1 2021Mar 31, 2021-$7.18M–
Q1 FY2021CQ4 2020Dec 31, 2020-$3.01M–
Q4 FY2020CQ3 2020Sep 30, 2020-$1.67M–
Q3 FY2020CQ2 2020Jun 30, 2020-$1.35M–
Q2 FY2020CQ1 2020Mar 31, 2020-$1.17M–
Q1 FY2020CQ4 2019Dec 31, 2019-$789.71K–
Q3 FY2019CQ2 2019Jun 30, 2019-$3.12M–
Q2 FY2019CQ1 2019Mar 31, 2019-$398.88K–
Q1 FY2019CQ4 2018Dec 31, 2018-$382.35K–
Q4 FY2018CQ3 2018Sep 30, 2018-$971.23K–
Q3 FY2018CQ2 2018Jun 30, 2018-$1.11M–
Q2 FY2018CQ1 2018Mar 31, 2018-$1.39M–
Q1 FY2018CQ4 2017Dec 31, 2017-$1.14M–
Q4 FY2017CQ3 2017Sep 30, 2017-$1.12M–
Q3 FY2017CQ2 2017Jun 30, 2017-$941.34K–
Q2 FY2017CQ1 2017Mar 31, 2017-$1.28M–
Q1 FY2017CQ4 2016Dec 31, 2016-$1.37M–
Q4 FY2016CQ3 2016Sep 30, 2016-$1.19M–

More Edesa Biotech figures

See a number that looks wrong?